🇺🇸 FDA
Pipeline program

Uteratonic administration

Sengul Ulucam

Unknown small_molecule active

Quick answer

Uteratonic administration for Placenta Abruptio is a Unknown program (small_molecule) at Tarsus Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
Tarsus Pharmaceuticals
Indication
Placenta Abruptio
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials